CHRISTOPHER PIVONKA: Open Payments
NPI 1881970044 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,348 in 80 payments from 16 companies in 2025. Trend: 2023 $1,369 · 2024 $1,290 · 2025 $1,348
Food & beverage: $1,348
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $337 |
| ABBVIE INC. | 27 | $314 |
| Novo Nordisk Inc | 7 | $151 |
| Axsome Therapeutics, Inc. | 10 | $143 |
| PFIZER INC. | 6 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| CVRx, Inc. | 1 | $41 |
| Boston Scientific Corporation | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
Products named: AIRSUPRA, Auvelity, Ozempic, QULIPTA, BREZTRI, NURTEC ODT, FARXIGA, UBRELVY.
Industry payments across TN — which companies pay providers there.
